Jasper Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Jasper Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q2 2024.
  • Jasper Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.48M, a 6.54% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.48M +$91K +6.54% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.17M -$98K -7.74% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q3 2023 $5.21M +$1.12M +27.4% Jul 1, 2023 Sep 30, 2023 10-K 2024-03-05
Q2 2023 $1.39M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.27M +$1.17M +1167% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $4.09M +$3.9M +1998% Jul 1, 2022 Sep 30, 2022 10-K 2024-03-05
Q1 2022 $100K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $195K -$121K -38.3% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q3 2020 $316K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.